Got $4,000? 4 Healthcare Stocks to Buy and Hold Forever
Altogether, allocating $4,000 into these four healthcare stocks on the TSX offers a balanced approach to investing in a sector that combines stability with growth potential. Each company presents ...
Stifel Nicolaus Reaffirms Their Buy Rating on Knight Therapeutics (KHTRF)
In a report released today, Justin Keywood from Stifel Nicolaus maintained a Buy rating on Knight Therapeutics (KHTRF – Research Report), with ...
Leede Financial Predicts TSE:CPH FY2027 Earnings
Stock analysts at Leede Financial issued their FY2027 earnings per share (EPS) estimates for Cipher Pharmaceuticals in a ...